PETER HIATT to Pseudomonas Infections
This is a "connection" page, showing publications PETER HIATT has written about Pseudomonas Infections.
Connection Strength
0.477
-
Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain. J Clin Microbiol. 2013 Apr; 51(4):1237-40.
Score: 0.096
-
Analysis of the associations between lung function and clinical features in preschool children with cystic fibrosis. Pediatr Pulmonol. 2012 Jun; 47(6):574-81.
Score: 0.088
-
Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. Arch Pediatr Adolesc Med. 2011 Sep; 165(9):847-56.
Score: 0.087
-
Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatr Pulmonol. 2007 Jul; 42(7):610-23.
Score: 0.065
-
Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Environ Microbiol. 2003 Dec; 5(12):1341-9.
Score: 0.051
-
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am J Respir Crit Care Med. 2003 Mar 15; 167(6):841-9.
Score: 0.048
-
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis. 2001 Feb 01; 183(3):444-52.
Score: 0.042